Cargando…

Acceleration of cutaneous T-cell lymphoma following dupilumab administration

Detalles Bibliográficos
Autores principales:	Russomanno, Kristen, Carver DeKlotz, Cynthia Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829113/ https://www.ncbi.nlm.nih.gov/pubmed/33532533 http://dx.doi.org/10.1016/j.jdcr.2020.12.010

Ejemplares similares

Cutaneous manifestations of tuberous sclerosis complex and the paediatrician's role
por: Cardis, Michael A, et al.
Publicado: (2017)

Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas
por: LAZARIDOU, Ingrid, et al.
Publicado: (2020)

Clearance of atypical cutaneous manifestations of hyper‐IgE syndrome with dupilumab
por: Nihal, Aman, et al.
Publicado: (2022)

Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab
por: Choo, Zi-Yi, et al.
Publicado: (2023)

Cutaneous T-cell Lymphoma Progression: A Potential Dupilumab Pitfall
por: Malick, Hamza, et al.
Publicado: (2023)

Treatment of angiokeratomas of Fordyce with topical rapamycin 0.25% cream
por: Bell, Katheryn A., et al.
Publicado: (2020)

Rapid resolution of widespread cutaneous lichen planus and generalized pruritus in an elderly patient following treatment with dupilumab
por: Kazemi, Soroush, et al.
Publicado: (2022)

Lethal anaplastic large-cell lymphoma occurring in a patient treated with dupilumab
por: Du-Thanh, Aurélie, et al.
Publicado: (2021)

A rare case of aggressive cytotoxic T-cell lymphoma in a patient on dupilumab
por: Ahatov, Renat, et al.
Publicado: (2022)

Eosinophilic pneumonia developed after dupilumab administration in a patient with atopic dermatitis
por: Kanata, Kei, et al.
Publicado: (2023)

Dupilumab in patients with chronic hepatitis B on concomitant entecavir
por: Ly, Karen, et al.
Publicado: (2019)

Dupilumab-associated blepharoconjunctivitis
por: Paulose, Sefy A., et al.
Publicado: (2019)

Ophiasis treated with dupilumab
por: Abercrombie, McKenna, et al.
Publicado: (2021)

Dupilumab-Induced Pancreatitis
por: Jasti, Vivek V., et al.
Publicado: (2023)

De novo case of lichenoid eruption following dupilumab treatment
por: Kim, Tae-Eun, et al.
Publicado: (2021)

Dupilumab-Induced Lichen Planus: A Case with Oral and Cutaneous Eruptions
por: Kern, Laura, et al.
Publicado: (2022)

Dupilumab as a treatment for cutaneous immune-related adverse events induced by immune checkpoint inhibitors: A case series and review of the literature
por: Fournier, Cynthia, et al.
Publicado: (2023)

Dupilumab Induced Limbal Stem Cell Deficiency
por: Mehta, Urmi, et al.
Publicado: (2021)

Blastoid mantle cell lymphoma: cutaneous infiltration()()
por: de Ré, Mariana Righetto, et al.
Publicado: (2021)

Dupilumab-induced erythema nodosum
por: Mustin, Danielle E., et al.
Publicado: (2021)

Dupilumab-induced pityriasis rosea
por: Zabel, Morgan, et al.
Publicado: (2023)

Relapse of Eosinophilic Esophagitis on Dupilumab
por: Buendia, Matthew A., et al.
Publicado: (2022)

Vitiligo during dupilumab therapy
por: Picone, Vincenzo, et al.
Publicado: (2023)

Pemphigoid gestationis treated with dupilumab
por: Chen, Rita E., et al.
Publicado: (2023)

Dupilumab-Associated Sezary Syndrome
por: Hamp, Austin, et al.
Publicado: (2023)

Dupilumab for the treatment of severe photodermatitis
por: Smith, Mary Patricia, et al.
Publicado: (2019)

CUTANEOUS INVOLVEMENT IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
por: Papadavid, Evangelia, et al.
Publicado: (2010)

Nivolumab-associated cutaneous T-cell lymphoma
por: Marks, Jennifer A., et al.
Publicado: (2021)

Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
por: Maillet-Lebel, Nicole, et al.
Publicado: (2016)

Primary Cutaneous Peripheral T-Cell Lymphoma Not Otherwise Specified: A Rapidly Progressive Variant of Cutaneous T-Cell Lymphoma
por: Aderhold, Kimberly, et al.
Publicado: (2015)

Dupilumab facial redness: Positive effect of itraconazole
por: de Beer, Fleur S.A., et al.
Publicado: (2019)

Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae
por: Vingopoulos, Filippos, et al.
Publicado: (2020)

Epidermolysis bullosa pruriginosa responding to dupilumab
por: Clawson, Rebecca C., et al.
Publicado: (2021)

Dupilumab-associated cicatrizing ocular disease
por: Reddy, Amit K., et al.
Publicado: (2022)

Infectious pseudochromhidrosis in the setting of dupilumab use
por: Kuo, Molly E., et al.
Publicado: (2022)

Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
por: Wu, Chenyu, et al.
Publicado: (2023)

Effects of dupilumab on keloid stabilization and prevention
por: Wittmer, Ashley, et al.
Publicado: (2023)

Management of immune-related cutaneous adverse events with dupilumab
por: Kuo, Alyce Mei-Shiuan, et al.
Publicado: (2023)

A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine
por: Lospinoso, Kristen, et al.
Publicado: (2021)

Skin-first nodulotumoral adult T-cell lymphoma mimicking cutaneous T-cell lymphoma
por: Cohen, Leah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v10tceoackq6v5alli2tgpt8sq